AI Designed Drugs Face Their Reckoning: Isomorphic Labs, Insilico's Phase 3, and Medicine's Make or Break Year - July 20, 2026

AI Designed Drugs Face Their Reckoning: Isomorphic Labs, Insilico's Phase 3, and Medicine's Make or Break Year Two milestones just turned AI drug discovery from promise into a real world test. Isomorphic Labs, the Google DeepMind spinoff built on the AlphaFold lineage, is moving its first AI designed molecules into human oncology trials, while Insilico Medicine has pushed rentosertib, an AI discovered treatment for the lung disease idiopathic pulmonary fibrosis, into a pivotal Phase 3 study...